Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) were up 14.1% during trading on Friday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). Approximately 9,747,062 shares were traded during mid-day trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).
Wall Street Analyst Weigh In
Several analysts have recently commented on SPI shares. JPMorgan Chase & Co. reduced their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research note on Tuesday, August 5th. Berenberg Bank reiterated a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Spire Healthcare Group currently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.
View Our Latest Stock Analysis on SPI
Spire Healthcare Group Price Performance
The firm has a market capitalization of £985.81 million, a price-to-earnings ratio of 5,326.09, a PEG ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The company's 50-day moving average is GBX 218.99 and its 200-day moving average is GBX 203.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. On average, research analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.